Top-News
Professionelle Dienstleistungen Großbritannien

Genedrive News

Aktie
WKN:  A0ML2T ISIN:  GB00B1VKB244
0,018 €
-0,001 €
-5,26%
20.05.24 12:29:05
Handeln Depot/Watchlist
Aktienanzahl *
63,32 Mio.
Marktkapitalisierung *
379,92 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 30.07.2021

Unternehmensmeldungen

05.02.20 - DGAP
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult 05-Feb-2020 / 07:15 GMT/BST Hardman & Co ...
21.11.19 - DGAP
Hardman & Co Research: genedrive plc (GDR): Regulatory hurdle leaped: hearing loss assay
Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Regulatory hurdle leaped: hearing loss assay 21-Nov-2019 / 12:30 GMT/BST Hardman & Co Res earch ...
28.10.19 - DGAP
Hardman & Co Research: genedrive plc (GDR): Acceleration of news flow expected
Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Acceleration of news flow expected 28-Oct-2019 / 07:30 GMT/BST Hardman & Co Res earch ...
18.07.19 - DGAP
Hardman & Co Research: genedrive plc (GDR): Hepatitis C market frustrations
Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Hepatitis C market frustrations 18-Jul-2019 / 07:30 GMT/BST
08.04.19 - DGAP
Hardman & Co Research: genedrive plc (GDR): First commercial sales in new focus area: bio-threats
Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): First commercial sales in new focus area: bio-​threats 08-Apr-2019 / 10:53 GMT/BST
11.12.18 - DGAP
Hardman & Co Research: genedrive plc (GDR): Accelerating into fiscal 2019 with first sales
Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Accelerating into fiscal 2019 with first sales 11-Dec-2018 / 07:15 GMT/BST
27.06.18 - DGAP
Hardman & Co Research: genedrive plc (GDR): Preventing hearing loss in newborns
Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Preventing hearing loss in newborns 27-Jun-2018 / 07:15 GMT/BST
12.04.18 - DGAP
Hardman & Co Research: genedrive plc (GDR): Progressing commercialisation plans
Hardman & Co Hardman & Co Research: genedrive plc (GDR): Progressing commercialisation plans 12-Apr-2018 / 09:51 GMT/BST
02.06.09 - Hugin
Epistem Presents Further Data Supporting Its Plucked Hair BiomarkerTechnology at the Institute of Cancer Research Centenary Conference
Data on the effects of gemcitabine on epithelial tissue released MANCHESTER, UNITED KINGDOM--(Marketwire - June 02, 2009) - Epistem plc (LSE: EHP), the UK biotechnology ...
20.04.09 - Hugin
Epistem Present at AACR Meeting in Denver
MANCHESTER, UNITED KINGDOM--(Marketwire - April 20, 2009) - Epistem plc (LSE: EHP), the UK biotechnology and contract research company, have presented results from their ...
14.04.09 - Hugin
Epistem to Present Erlotinib Biomarker Data at AACR Meeting
MANCHESTER, UNITED KINGDOM--(Marketwire - April 14, 2009) - Epistem plc (LSE: EHP), the UK biotechnology and contract research company, will present results from its ...
07.04.08 - Hugin
Epistem to Announce Data on Its Stem Cell Cancer Assays at AACR
MANCHESTER, UK--(Marketwire - April 04, 2008) - Epistem Plc (LSE: EHP), the UK epithelial stem cell company, announced today that data on its cancer stem cell assays will be ...
07.04.08 - Hugin
Epistem to Announce Data on Its Stem Cell Cancer Assays at AACR
MANCHESTER, UK--(Marketwire - April 04, 2008) - Epistem Plc (LSE: EHP), the UK epithelial stem cell company, announced today that data on its cancer stem cell assays will be ...

Newssuche

Videos

newspaper
17.05.24 +6,63%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »